BIOR News and Press, Biora Therapeutics Inc. From 05/19/22

Biora Therapeutics (NASDAQ:BIOR +4.5%) said on Thursday it had received a new patent related to its Drug Delivery System platform, which is under development. The company said the technology is applicable to any ingestible device, whether the device is for sampling, diagnostics, or ...

SAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced a new patent related to its Drug Delivery System (DDS) platform under development. The USPTO has issued U.S. Patent No. 10,83...

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company’s management team will be presenting a corporate overview and participating in one-on-one meetings, upon re...

The following slide deck was published by Biora Therapeutics, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Biora Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation

Biora Therapeutics, Inc. (BIOR) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Chuck Padala – Managing Director, LifeSci Advisors Adi Mohanty – Chief Executive Officer Eric d’Esparbes – Chief Financial Officer Conference Call Particip...